Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19

Research Question:
How is the body's immune response to natural SARS-CoV-2 infection characterized?

Basic Study Information

Purpose:
The purpose of this study is to learn more about infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this virus by the name "coronavirus." It can cause the disease called COVID-19. The information gained from the study will be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines and treatments by allowing researchers to determine the difference between the body's immune response to natural SARS-CoV-2 infection and immunization with a SARS-CoV-2 vaccine. Inclusion Criteria: Age 18 or older / Have had a positive test for SARS-CoV-2 / Reports resolution of COVID-19 within 1-8 weeks of enrollment OR, if asymptomatic infection, reports positive SARS-CoV-2 test within 2-10 weeks of enrollment.

Location: University of Rochester Vaccines to Prevent HIV Infection CRS
Study Reference #: 4970

Lead Researcher (Principal Investigator)

Lead Researcher:  Michael Keefer

Study Contact Information

Study Coordinator: CRS Leader
Phone: (585) 275-5871
Email: michael_keefer@urmc.rochester.edu

Additional Study Details

Return to Search